Editas Medicine (EDIT) Stock Chart & Stock Price History $2.56 +0.31 (+13.78%) Closing price 04:00 PM EasternExtended Trading$2.64 +0.09 (+3.32%) As of 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine Stock Price Performance The Editas Medicine (EDIT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 43.61%, with a year-to-date return of 101.57%. In the past month, the stock has increased 44.63%, reflecting recent market activity. As of the latest close, Editas Medicine traded at $2.25 with a market cap of $188.35 million and volume of 1.75 million shares. Five years ago, the stock traded at $30.53, representing a 91.61% decrease over that period. At the time, it had a market cap of $1.70 billion and a volume of 955,783 shares. Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.28%1 Month Performance+44.63%3 Month Performance+116.95%Year-To-Date Performance+101.57%1 Year Performance-43.61%5 Year Performance-91.61% EDIT Stock Chart for Wednesday, July, 2, 2025 EDIT Chart by TradingView Editas Medicine Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$2.20$2.25+2.27%$2.31$2.111.75 million shs$188.35 million06/30/2025$2.28$2.20-3.51%$2.37$2.192.24 million shs$184.17 million06/27/2025$2.12$2.28+7.55%$2.33$2.135.46 million shs$190.86 million06/26/2025$2.19$2.12-3.20%$2.22$2.082.31 million shs$177.47 million06/25/2025$2.25$2.19-2.67%$2.29$2.142.26 million shs$183.33 million06/24/2025$2.10$2.25+7.14%$2.31$2.153.02 million shs$188.35 million06/23/2025$2.22$2.10-5.41%$2.24$2.021.78 million shs$175.79 million06/20/2025$2.35$2.22-5.53%$2.39$2.153.06 million shs$185.84 million06/19/2025$2.35$2.35$2.38$2.053.58 million shs$196.72 million06/18/2025$2.14$2.35+9.81%$2.38$2.053.58 million shs$196.72 million Get the Latest News and Ratings for EDIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$2.16$2.14-0.93%$2.55$2.105.46 million shs$179.15 million06/16/2025$1.97$2.16+9.64%$2.20$1.942.81 million shs$180.82 million06/13/2025$2.18$1.97-9.63%$2.12$1.943.05 million shs$164.92 million06/12/2025$2.03$2.18+7.39%$2.30$1.973.19 million shs$182.49 million06/11/2025$2.10$2.03-3.33%$2.19$2.012.01 million shs$169.94 million06/10/2025$1.93$2.10+8.81%$2.23$1.922.88 million shs$175.80 million06/09/2025$1.91$1.93+1.05%$2.02$1.851.22 million shs$161.57 million06/06/2025$1.80$1.91+6.11%$1.97$1.802.45 million shs$159.89 million06/05/2025$1.82$1.80-1.10%$1.98$1.733.18 million shs$150.68 million06/04/2025$1.82$1.82$1.85$1.77866,076 shs$152.36 million06/03/2025$1.77$1.82+2.82%$1.87$1.661.65 million shs$152.36 million06/02/2025$1.74$1.77+2.02%$1.92$1.752.17 million shs$148.17 million Related Companies Pharming Group Stock Chart Replimune Group Stock Chart Cronos Group Stock Chart Xeris Biopharma Stock Chart Vir Biotechnology Stock Chart Gyre Therapeutics Stock Chart Sionna Therapeutics Stock Chart Nuvation Bio Stock Chart AnaptysBio Stock Chart Phathom Pharmaceuticals Stock Chart Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EDIT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EDIT Stock Alerts